Carlsmed, Inc. (CARL): Operating Income

Annual figures by period end, from SEC filings.

-$30.57M

Year ended 2025-12-31

-$38.66M

Trailing 12 months to 2026-06-30

2024-12-31 Operating Income (USD) 2025-12-31

Period ended	Operating Income	Change YoY	Source filing
2025-12-31	-$30.57M	n/m	2026-02-25, From 2025-01-01
2024-12-31	-$24.12M	n/a	2026-02-25, From 2024-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
Carlsmed, Inc. (CARL)	2025-12-31	-$30.57M	n/m
Apyx Medical Corp (APYX)	2025-12-31	-$6.45M	n/m
Shoulder Innovations, Inc. (SI)	2025-12-31	-$26.30M	n/m
TriSalus Life Sciences, Inc. (TLSI)	2025-12-31	-$26.95M	n/m
CVRx, Inc. (CVRX)	2025-12-31	-$51.27M	n/m
SANUWAVE Health, Inc. (SNWV)	2025-12-31	$4.95M	+28.5%
LENSAR, Inc. (LNSR)	2025-12-31	-$24.58M	n/m
SS Innovations International, Inc. (SSII)	2025-12-31	-$8.19M	n/m
Meihua International Medical Technologies Co., Ltd. (MHUAF)	2025-12-31	$8.28M	-42.1%

Compare CARL, APYX, SI, TLSI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗